Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Terminated 5Withdrawn 1Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Glioblastoma 44Glioma 16Melanoma 11Central Nervous System Neoplasms 11Astrocytoma 11Brain Neoplasms 10Oligodendroglioma 7Gliosarcoma 5Small Cell Lung Carcinoma 4Recurrence 3Lymphoma 3Leiomyosarcoma 3Sarcoma 2Neoplasms, Neuroepithelial 2Neoplasms 2Neoplasm Metastasis 2Ependymoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Uveal Melanoma 1Seizures 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pituitary Neoplasms 1

Interventions

Carboplatin 84Cisplatin 79Pemetrexed 72Docetaxel 62Drug Therapy 44Gemcitabine 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 26camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 14Surgical Procedures, Operative 13Immunotherapy 13Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × Temozolomide × Clear all
NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
381 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡